A Randomized Controlled Clinical Trial on the Efficacy and Safety of Fenofibrate Combined With Ursodeoxycholic Acid in PBC Patients With an Incomplete Biochemical Response to UDCA
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Ursodeoxycholic acid (Primary) ; Fenofibrate
- Indications Cholangitis
- Focus Therapeutic Use
Most Recent Events
- 12 Sep 2021 Planned End Date changed from 1 Jan 2019 to 8 Sep 2021.
- 12 Sep 2021 Planned primary completion date changed from 1 Jan 2019 to 8 Sep 2021.
- 12 Sep 2021 Status changed from recruiting to withdrawn prior to enrolment.